{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:08:00Z","timestamp":1793383680685,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/ki.2014.408","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T19:06:00Z","timestamp":1421867160000},"page":"698-711","source":"Crossref","is-referenced-by-count":390,"title":["Diagnosis of monoclonal gammopathy of renal significance"],"prefix":"10.1016","volume":"87","author":[{"given":"Frank","family":"Bridoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the International Kidney and Monoclonal Gammopathy Research Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin A.","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Fermand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Picken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo A.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C.","family":"Fervenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samih H.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2014.408_bb0010","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJM199106273242603","article-title":"Nephrotoxic potential of Bence Jones proteins","volume":"324","author":"Solomon","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.408_bb0015","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1001\/archinte.1990.00040031693017","article-title":"Renal failure in multiple myeloma. Pathogenesis and prognostic implications","volume":"150","author":"Alexanian","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.2014.408_bb0020","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2006-03-008953","article-title":"Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials","volume":"108","author":"Drayson","year":"2006","journal-title":"Blood"},{"key":"10.1038\/ki.2014.408_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJM197007162830304","article-title":"Pathology of the kidney in Waldenstrom's macroglobulinemia. Study of sixteen cases","volume":"283","author":"Morel-Maroger","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.408_bb0030","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","article-title":"Dangerous small B-cell clones","volume":"108","author":"Merlini","year":"2006","journal-title":"Blood"},{"key":"10.1038\/ki.2014.408_bb0035","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2013.50.8499","article-title":"Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis","volume":"31","author":"Kourelis","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1038\/ki.2014.408_bb0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution","volume":"7","author":"Nasr","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0045","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"10.1038\/ki.2014.408_bb0050","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1053\/j.ajkd.2003.08.040","article-title":"Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors","volume":"42","author":"Pozzi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0055","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"10.1038\/ki.2014.408_bb0060","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa070484","article-title":"High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis","volume":"357","author":"Jaccard","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.408_bb0065","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"key":"10.1038\/ki.2014.408_bb0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ajkd.2005.05.010","article-title":"Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis","volume":"46","author":"Leung","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0075","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/ndt\/gfm918","article-title":"Long-term outcome of autologous stem cell transplantation in light chain deposition disease","volume":"23","author":"Lorenz","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.408_bb0080","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1523-1755.2002.00628.x","article-title":"Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features","volume":"62","author":"Bridoux","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0085","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2215\/CJN.10611110","article-title":"Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab","volume":"6","author":"Guiard","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.2010.30.5235","article-title":"Outcome in renal Al amyloidosis after chemotherapy","volume":"29","author":"Pinney","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/ki.2014.408_bb0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ki.2008.577","article-title":"Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits","volume":"75","author":"Czarnecki","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-term outcome of renal transplantation in light-chain deposition disease","volume":"43","author":"Leung","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2215\/CJN.05750710","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-6143.2012.04326.x","article-title":"Renal transplantation in systemic amyloidosis-importance of amyloid fibril type and precursor protein abundance","volume":"13","author":"Pinney","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2014.408_bb0115","article-title":"Clinical Findings, Pathology, and Outcomes of C3GN after Kidney Transplantation","author":"Zand","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1053\/j.ajkd.2006.01.004","article-title":"Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation","volume":"47","author":"Sanada","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0125","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2014.408_bb0130","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.408_bb0135","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1681\/ASN.2012060577","article-title":"Recurrent membranous nephropathy in an allograft caused by IgG3kappa targeting the PLA2 receptor","volume":"23","author":"Debiec","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0140","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0145","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.408_bb0150","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/ki.2014.408_bb0155","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1182\/blood-2011-10-388462","article-title":"Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival","volume":"119","author":"Venner","year":"2012","journal-title":"Blood"},{"key":"10.1038\/ki.2014.408_bb0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5858\/134.4.545","article-title":"Amyloidosis-where are we now and where are we heading?","volume":"134","author":"Picken","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/ki.2014.408_bb0165","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1182\/blood-2013-01-453001","article-title":"Systemic light chain amyloidosis: an update for treating physicians","volume":"121","author":"Merlini","year":"2013","journal-title":"Blood"},{"key":"10.1038\/ki.2014.408_bb0170","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis","volume":"346","author":"Lachmann","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.408_bb0175","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/ki.2013.558","article-title":"Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis","volume":"86","author":"Said","year":"2014","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0180","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0185","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2215\/CJN.00650110","article-title":"The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies","volume":"5","author":"Fish","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0190","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2215\/CJN.11161111","article-title":"Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases","volume":"7","author":"Leung","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0195","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/j.ajkd.2004.12.020","article-title":"Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia","volume":"45","author":"Bridoux","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005792-200005000-00002","article-title":"Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients","volume":"79","author":"Messiaen","year":"2000","journal-title":"Medicine"},{"key":"10.1038\/ki.2014.408_bb0205","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/gfr381","article-title":"Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney","volume":"27","author":"Eirin","year":"2012","journal-title":"Nephrol Dia Transplant"},{"key":"10.1038\/ki.2014.408_bb0210","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/ndt\/gfu045","article-title":"Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist","volume":"29","author":"Sicard","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.408_bb0215","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"55","author":"Katzmann","year":"2009","journal-title":"Clin Chem"},{"key":"10.1038\/ki.2014.408_bb0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1373\/clinchem.2008.117143","article-title":"Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine","volume":"55","author":"Palladini","year":"2009","journal-title":"Clin Chem"},{"key":"10.1038\/ki.2014.408_bb0225","doi-asserted-by":"crossref","first-page":"908","DOI":"10.6004\/jnccn.2009.0061","article-title":"NCCN clinical practice guidelines in oncology: multiple myeloma","volume":"7","author":"Anderson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/ki.2014.408_bb0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1038\/ki.2014.408_bb0235","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2215\/CJN.06760909","article-title":"Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy","volume":"5","author":"Sethi","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0240","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin Chem"},{"key":"10.1038\/ki.2014.408_bb0245","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1309\/AJCPNS6K1CYJPDBA","article-title":"Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies","volume":"130","author":"Davern","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/ki.2014.408_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2013.01.014","article-title":"Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine","volume":"391","author":"Campbell","year":"2013","journal-title":"J Immunol Methods"},{"key":"10.1038\/ki.2014.408_bb0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jim.2004.08.002","article-title":"ELISAs for free human immunoglobulin light chains in serum: improvement of assay specificity by using two specific antibodies in a sandwich detection method","volume":"293","author":"Nakano","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1038\/ki.2014.408_bb0260","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1515\/CCLM.2011.624","article-title":"N Latex FLC-new monoclonal high-performance assays for the determination of free light chain kappa and lambda","volume":"49","author":"te Velthuis","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1038\/ki.2014.408_bb0265","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","author":"Hutchison","year":"2008","journal-title":"BMC Nephrol"},{"key":"10.1038\/ki.2014.408_bb0275","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/ki.2014.408_bb0280","series-title":"Monoclonal gammopathies and the kidney","first-page":"95","article-title":"Ultrastructural pattern and classification of renal monoclonal immunoglobulin deposits","author":"Touchard","year":"2003"},{"key":"10.1038\/ki.2014.408_bb0285","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5858\/2006-130-165-LATINA","article-title":"Light-chain-mediated acute tubular interstitial nephritis: a poorly recognized pattern of renal disease in patients with plasma cell dyscrasia","volume":"130","author":"Gu","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/ki.2014.408_bb0290","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.ajkd.2013.09.007","article-title":"Membranoproliferative glomerulonephritis: the role for laser microdissection and mass spectrometry","volume":"63","author":"Jain","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ki.2012.414","article-title":"The diagnosis and characteristics of renal heavy-chain and heavy\/light-chain amyloidosis and their comparison with renal light-chain amyloidosis","volume":"83","author":"Nasr","year":"2013","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0300","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/PAP.0b013e3182a92dc3","article-title":"Modern approaches to the treatment of amyloidosis: the critical importance of early detection in surgical pathology","volume":"20","author":"Picken","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/ki.2014.408_bb0305","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.micron.2008.10.002","article-title":"Optical properties of amyloid stained by Congo red: history and mechanisms","volume":"40","author":"Howie","year":"2009","journal-title":"Micron"},{"key":"10.1038\/ki.2014.408_bb0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00737143","article-title":"Renal amyloidosis. Correlations between morphology, chemical types of amyloid protein and clinical features","volume":"412","author":"Shiiki","year":"1988","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1038\/ki.2014.408_bb0315","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000096765","article-title":"Immunoglobulin light and heavy chain amyloidosis AL\/AH: renal pathology and differential diagnosis","volume":"153","author":"Picken","year":"2007","journal-title":"Contrib Nephrol"},{"key":"10.1038\/ki.2014.408_bb0320","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2012.108","article-title":"Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0325","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2215\/CJN.07030712","article-title":"Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy","volume":"8","author":"Sethi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0330","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/01913121003672873","article-title":"Ultrastructural immunolabeling in the diagnosis of monoclonal light-and heavy-chain-related renal diseases","volume":"34","author":"Herrera","year":"2010","journal-title":"Ultrastruct Pathol"},{"key":"10.1038\/ki.2014.408_bb0335","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0340","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features","volume":"63","author":"Rosenstock","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0345","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1093\/ndt\/gfs348","article-title":"Immunotactoid glomerulopathy: clinicopathologic and proteomic study","volume":"27","author":"Nasr","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.408_bb0350","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases","volume":"92","author":"Terrier","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1038\/ki.2014.408_bb0355","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.ki.5000123","article-title":"Dysproteinemia, proteinuria, and glomerulonephritis","volume":"69","author":"Nasr","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0360","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1053\/ajkd.2002.36350","article-title":"Renal involvement in monoclonal (type I) cryoglobulinemia: two cases associated with IgG3 kappa cryoglobulin","volume":"40","author":"Karras","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0365","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.5858\/2007-131-1368-ETPSOI","article-title":"Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy","volume":"131","author":"Kapur","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/ki.2014.408_bb0370","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/sj.ki.5001990","article-title":"Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies","volume":"70","author":"Nasr","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0375","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/hupa.2003.27","article-title":"Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy","volume":"34","author":"Gu","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1038\/ki.2014.408_bb0380","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1053\/j.ajkd.2009.08.010","article-title":"Plasma cell dyscrasia causing light chain tubulopathy without Fanconi syndrome","volume":"55","author":"Elliott","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0385","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1093\/ndt\/gfl363","article-title":"Light chain tubulopathy without Fanconi syndrome","volume":"21","author":"Said","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.408_bb0390","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/modpathol.2011.104","article-title":"The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation","volume":"24","author":"Larsen","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/ki.2014.408_bb0395","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5858\/133.2.249","article-title":"Renal lesions associated with plasma cell dyscrasias: practical approach to diagnosis, new concepts, and challenges","volume":"133","author":"Herrera","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/ki.2014.408_bb0400","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/ndt\/gfq129","article-title":"Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome","volume":"25","author":"El Hamel","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.408_bb0405","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.ki.5001524","article-title":"Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis","volume":"70","author":"Stokes","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0410","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: the disease spectrum","volume":"12","author":"Lin","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0415","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1053\/j.ajkd.2011.05.022","article-title":"Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature","volume":"58","author":"Alexander","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1523-1755.2004.00365.x","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis","volume":"65","author":"Nasr","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0425","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5414\/CN107230","article-title":"Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenstrom's macroglobulinemia: case report and review of the literature","volume":"77","author":"Yahata","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2014.408_bb0430","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/j.ajkd.2005.10.023","article-title":"A proliferative glomerulonephritis secondary to a monoclonal IgA","volume":"47","author":"Soares","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0435","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0046-8177(85)80017-4","article-title":"Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis","volume":"16","author":"Alpers","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1038\/ki.2014.408_bb0440","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.408_bb0445","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","article-title":"Dense deposit disease associated with monoclonal gammopathy of undetermined significance","volume":"56","author":"Sethi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0450","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","article-title":"C3 glomerulonephritis associated with monoclonal gammopathy: a case series","volume":"62","author":"Zand","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.408_bb0455","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2215\/CJN.06180710","article-title":"Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?","volume":"6","author":"Bridoux","year":"2011","journal-title":"Clin Am Soc Nephrol"},{"key":"10.1038\/ki.2014.408_bb0460","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.mayocp.2013.08.002","article-title":"Monoclonal gammopathy-associated proliferative glomerulonephritis","volume":"88","author":"Sethi","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/ki.2014.408_bb0465","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815302179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815302179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T06:52:51Z","timestamp":1690872771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815302179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0085253815302179"],"URL":"https:\/\/doi.org\/10.1038\/ki.2014.408","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}